| Authors: |
Heller NH; Center for Psychedelic and Consciousness Research, Johns Hopkins University School of Medicine, Baltimore, MD 21224, United States.; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205, United States., Barrett FS; Center for Psychedelic and Consciousness Research, Johns Hopkins University School of Medicine, Baltimore, MD 21224, United States.; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205, United States.; Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205, United States.; Department of Psychological and Brain Sciences, Johns Hopkins University, Baltimore, MD 21218, United States., Buchborn T; Institute of Psychopharmacology, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, 68159 Mannheim, Germany., Collerton D; School of Psychology, Faculty of Medical Sciences, Campus for Ageing and Vitality, Newcastle University, Newcastle upon Tyne, NE4 5PL, United Kingdom., Dupuis D; Institut national de la santé et de la recherche médicale (INSERM), Paris, 75013, France., Halberstadt AL; Department of Psychiatry, University of California San Diego, San Diego, CA 92093, United States.; Research Service, Veterans Affairs San Diego Healthcare System, San Diego, CA 92161, United States., Jardri R; University of Lille, INSERM U-1172, Lille Neurosciences & Cognition Centre (LilNCog), CURE Platform, Fontan Hospital, CHU Lille, 59000, France., Noorani T; School of Pharmacy, University of Auckland, Auckland, 1142, New Zealand., Preller KH; Department of Adult Psychiatry and Psychotherapy, Psychiatric University Clinic Zurich, Zurich, 8032, Switzerland.; University of Zurich, Zurich, 8032, Switzerland., Taylor JP; Newcastle University, Translational and Clinical Research Institute Newcastle upon Tyne, Tyne and Wear, NE4 5PL, United Kingdom., Waters F; School of Psychology, University of Western Australia, Nedlands, WA, 6009, Australia.; Early Psychosis Program, Black Swan Health, Osborne Park, WA, 6017, Australia., Winston BS; Center for Psychedelic and Consciousness Research, Johns Hopkins University School of Medicine, Baltimore, MD 21224, United States.; Department of Psychological and Brain Sciences, Johns Hopkins University, Baltimore, MD 21218, United States., Leptourgos P; University of Lille, INSERM U-1172, Lille Neurosciences & Cognition Centre (LilNCog), CURE Platform, Fontan Hospital, CHU Lille, 59000, France. |
